ORLANDO, FL – June, 29th 2020 – Anubis Bio, the parent company behind DoggyStat, the first product of its kind to use passive immunity to treat canine diarrhea, announced today the addition of Dr. Jan Suchodolski (MedVet, DrVetMed, Ph.D., AGAF, DACVM) to the company’s Advisory Team. Dr. Suchodolski is a widely regarded researcher and professor in the studies of gastrointestinal function testing, gastrointestinal pathogens, and intestinal microbial ecology. He joins the advisory team at Anubis Bio at an exciting time with the work the company is doing to introduce innovative products, led by DoggyStat, for the treatment of infections in animals.
Dr. Jan Suchodolski is an Associate Professor of Small Animal Internal Medicine and Associate Director for Research of the GI Lab at Texas A&M University. His research has an emphasis on probiotics and prebiotics and how intestinal pathogens lead to disturbances in the intestinal microbiome of companion animals. Dr. Suchodolski is a graduate of the University of Vienna in Austria. He has authored or coauthored more than 240 peer-reviewed articles on veterinary gastroenterology and microbiome research. Dr. Suchodolski earned his PhD in veterinary microbiology from Texas A&M University.
“We are more than excited to have Dr. Jan Suchodolski join our Advisory Team” said Tom Schultz, Founder and CEO of Anubis Bio, “As a thought leader in the areas of gastrointestinal function, testing, pathogens, and intestinal microbial ecology, Dr. Suchodolski is regarded as an expert and top researcher in animal GI health.” Dr. Suchodolski will provide support to Anubis Bio across clinical trials, new product development, and research advisory.
With the recent close of Anubis Bio’s oversubscribed $1M seed round earlier this year, the company’s stronger than forecast revenue growth in 2020, the announcement in April that Dr. Marty Becker, “America’s Veterinarian” had joined the advisory team, and now the addition of Dr. Jan Suchodolski, it’s an exciting time for Anubis Bio and the momentum the company continues to experience in the animal life science industry.
ABOUT ANUBIS BIO
Anubis Bio is an animal health company employing passive immunity for the treatment of infections in animals. The Company was founded in 2018 and is led by CEO Tom Schultz, a founder of multiple technology companies, including those with IPO, NASDAQ, and 9-figure exits. Tom holds a B.E.S degree from Johns Hopkins University and an MBA from Harvard Business School. Anubis Bio has assembled a strong group of advisors and directors to help build the business and build an effective management team. The company’s lead product, DoggyStat, delivers fast-acting immune factors to the GI tract to support rapid relief of acute canine diarrhea.
DoggyStat is a safe, easy to use, dietary supplement that supports the rapid resolution of acute canine diarrhea. The company’s proprietary platform creates products that deliver fast-acting antibodies to the GI tract that work with a dog’s system to neutralize bacterial and viral pathogens to relieve diarrhea and restore normal gut function. A single dose typically resolves diarrhea within 12-24 hours. Administration of DoggyStat is simple, the powder can be mixed with food or water and fed to the pet; animals find it very palatable. DoggyStat has no known side effects or overdose risk making it safe for dogs of all ages and sizes.
DoggyStat is available wholesale via RJ Matthews, with over 20,000 pet retailer accounts nationwide; VetCove, the largest B2B veterinary marketplace, serving over 7,000 vet clinics and hospitals; and Anubis Bio wholesale direct (wholesale.doggystat.com). Retail DoggyStat is available through Amazon and www.doggystat.com.
ABOUT DR. JAN SUCHODOLSKI
Dr. Jan S. Suchodolski (MedVet, DrVetMed, Ph.D., AGAF, DACVM) graduated with a veterinary degree from the University of Veterinary Medicine in Vienna, Austria in 1997. After working for several years in a small animal specialty clinic he returned to academia and received his Dr. med. vet. degree from the University of Vienna, Austria in recognition for his research on potential diagnostic markers for canine gastric disease.
In 2005 Dr. Suchodolski received his PhD in Veterinary Microbiology from Texas A&M University for his work on molecular markers for the assessment of the intestinal microbiota. He is also board certified in immunology by the American College of Veterinary Microbiologists (ACVM). He currently serves as Associate Professor of Small Animal Internal Medicine and Associate Director for Research of the GI Lab at Texas A&M University
Tom Schultz, 480-231-7832